News

High sodium concentrations in the brains of patients with multiple sclerosis (MS) may be associated with higher levels of disability in patients with MS, particularly those with progressive disease.

New research indicates that patients with multiple sclerosis (MS) who have high levels of education may be less likely to suffer from cognitive impairment related to MS than patients with MS and lower levels of education.

Recent research from the University of Michigan Health Systems published in JAMA Internal Medicine found that hospitals with the highest rates of cardiac arrests are more likely to have the poorest survival rates for those cases.

University of Florida researchers analyzed anonymous network utilization records for workstations in the emergency department (ED) at one academic medical center for 15 days, and after comparing the data to ED work index data from hospital information systems, they found that health care workers spent a substantial amount of staff time on Facebook.

The largest study to date on reducing rates of methicillin-resistant Staphylococcus aureus (MRSA) infections in ICU patients found that bloodstream infections in these patients can be reduced by more than 40 percent through universal decolonization practices.

Steven P. Levine, MD, says new research on an old medicine has injected excitement into major depressive disorder treatment.

The US Food and Drug Administration (FDA) has expanded the indications of Novartis Pharmaceuticals Corp.'s transdermal therapy for Alzheimer's disease to include the treatment of patients with severe stages of the neurological disorder.

The US Food and Drug Administration (FDA) has approved Noven Pharmaceuticals Inc.'s once-daily Brisdelle (paroxetine) capsules to reduce moderate to severe hot flashes and night sweats that can last up to five years in menopausal women.

New research indicates that adenotonsillectomy helps children with sleep apnea sleep better, reduces restlessness and impulsivity, and improves their quality of life

Study shows use of Nissen fundoplication for GERD has fallen, with fewer procedures performed at high-volume centers and more at urban non-teaching hospitals.

Survey reveals explosive growth in the popularity of upper-arm liposuction and brachioplasty among women.

Recent studies reveal more information on the effects of menopausal status and sleep-disordered breathing on bariatric surgery outcomes. Also, the FDA is reviewing a new agent that may help ensure a faster and safer postsurgical recovery for morbidly obese patients.

Study shows that increased noise in the OR can impair communications between members of the operating team, and reducing ambient noise in may increase patient safety and reduce the risk of error.

Study shows gluten alters bowel functions in patients with IBS-D and that removal of gluten from the diet may reduce the frequency of bowel movements.

Recognizing that melatonin secretion from the gastrointestinal (GI) tract improves abdominal pain in irritable bowel syndrome (IBS) but decreases with age, Polish researchers from the Medical University of Lodz aimed to define the effect of administering melatonin in postmenopausal women with different predominating IBS symptoms.

Results of a pair of phase 3 placebo-controlled clinical studies conducted by a worldwide team of researchers have deemed Merck's Isentress (raltegravir) antiretroviral treatment safe, tolerable, and effective in multidrug-resistant HIV patients who are naïve to integrase inhibitors.

Though it's common medical knowledge that an ulcer eating a hole through a patient's stomach requires immediate surgical treatment as a result of its life-threatening nature, new findings from a team of Danish researchers urge physicians to beat the clock in performing emergency surgery on perforated peptic ulcers (PPU).

Citing a need for new therapies to remedy serious diseases acquired in hospitals, the US Food and Drug Administration has expanded approval of Vibativ (telavancin) to treat bacterial pneumonia when alternative drugs aren't appropriate.

The US Food and Drug Administration has awarded "breakthrough therapy" status to a synthetic copy of a naturally occurring human hormone for the treatment of acute heart failure (AHF), drug developer Novartis announced today.

The chronic constipation associated with conditions such as IBS can lead to serious health complications if left untreated.

The Diabetes Resource Guide highlights 20 websites that feature articles on topics such as ways to address and improve lifestyle factors (such as diet), how to live day to day with diabetes, information about diabetes medications, online forums, and more.

To help physicians take a step towards more personalized treatment for patients infected with hepatitis C virus (HCV), the US Food and Drug Administration today approved a fully automated test that can distinguish the seven major HCV genotypes in an infected patient.

Nearly two years after Eli Lilly and Co. halted a pair of clinical trials on its gamma-secretase inhibitor for Alzheimer's disease following the candidate's failure to demonstrate results superior to placebo, the drug maker has terminated a phase 2 study of its investigational beta-secretase (BACE) inhibitor for the same neurological condition - this time citing liver abnormalities.

Informative video lecture on the basics of hyponatremia and management.

Patients with decompensated heart failure and hyponatremia treated with standard management experienced worse outcomes than non-hyponatremic patients. Treatment with tolvaptan was associated with more favorable outcomes.

Study finds hyponatremia is an independent predictor of increased mortality, length of hospital stay, and postoperative complications in patients who undergo cardiac surgery.

Researchers recommended long-term surveillance of patients with hyponatremia on discharge.

Dr. Lim discusses the challenges of diagnosing and treating lupus, the tools and resources offered by the Lupus Initiative, and the impact of unconscious bias on care.

Merck & Co. has ceased development of its experimental therapy for Parkinson's disease after the drug failed to show superiority to placebo in initial data from a series of phase III clinical trials.

A high-potency probiotic supplement that mimics the effect of morphine in the gut may reduce the development of visceral pain in irritable bowel syndrome (IBS).